ARIAD Announces U.S. Food and Drug Administration Acceptance of NDA Filing for Brigatinib Life Science Investing
Immunotherapy Expert Dr. Brian Barnett Joins OncBioMune Scientific Advisory Board Pharmaceutical Investing
Ligand Partner Melinta Therapeutics Submits Baxdela New Drug Application for Hospital-Treated Skin Infections Biotech Investing
Braeburn Pharmaceuticals and Camurus Expand Collaboration and License Agreement Life Science Investing
Puma Biotechnology Announces Underwriters’ Full Exercise of Option to Purchase Additional Shares Biotech Investing
